Dynamics of Acute Liver Injury in Experimental Models of Hepatotoxicity in the Context of Their Implementation in Preclinical Studies on Stem Cell Therapy

被引:8
|
作者
Czekaj, Piotr [1 ]
Krol, Mateusz [1 ]
Limanowka, Lukasz [2 ]
Skubis-Sikora, Aleksandra [1 ]
Kolanko, Emanuel [1 ]
Bogunia, Edyta [1 ]
Hermyt, Mateusz [1 ]
Michalik, Marcin [1 ]
Sikora, Bartosz [1 ]
Prusek, Agnieszka [1 ]
Grajoszek, Aniela [3 ]
Pajak, Jacek [4 ]
机构
[1] Med Univ Silesia, Fac Med Sci Katowice, Dept Cytophysiol, Chair Histol & Embryol, PL-40752 Katowice, Poland
[2] Med Univ Silesia, Fac Med Sci Katowice, Chair Histol & Embryol, Students Sci Soc, PL-40752 Katowice, Poland
[3] Med Univ Silesia, Dept Expt Med, PL-40752 Katowice, Poland
[4] Med Univ Silesia, Fac Med Sci Katowice, Dept Pathomorphol & Mol Diagnost, PL-40752 Katowice, Poland
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2022年 / 27卷 / 08期
关键词
experimental models of hepatotoxicity; galactosamine; carbon tetrachloride; acute liver failure; stem cell therapy; HEPATOCYTE GROWTH-FACTOR; C-MET EXPRESSION; HEPATIC-FAILURE; FIBROSIS; TRANSPLANTATION; MICE; INJECTION; RAT; REGENERATION; DEGRADATION;
D O I
10.31083/j.fbl2708237
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background and Aims: Experimental models using carbon tetrachloride (CCl4) and D-galactosamine (D-GalN) can be used in preclinical assessment of acute liver failure (ALF) therapies. Unfortunately, these models are characterized by different dynamics of liver injury depending on the animal strain, administered hepatotoxin, and its dose. The aim of this study was to compare known rat and mouse models of ALF with a view to their future introduction into preclinical cell therapy experiments. In particular, based on histopathological and molecular changes, we suggested experimental time cut-off points for an effective stem cell therapeutic intervention. Methods: ALF was induced by a single intraperitoneal injection of CCl4 in mice (50 mu L/100 g b.w.) and rats (200 mu L/100 g b.w.) and D-GalN in mice (150 mg/100 g b.w.) and rats (50 mg/100 g b.w.). Blood and liver samples were collected 12 h, 24 h, 48 h and 7 days after intoxication. Blood morphology, liver function blood tests, histopathological changes, proliferation activity, apoptosis, fibrosis, and gene expression were analysed to assess liver damage. Results: At 12 h, 24 h, and 48 h after CCl4 injection, mouse livers showed moderate inflammatory infiltration and massive pericentral necrosis. In rats treated with CCl4, minor lymphocytic infiltration in the liver parenchyma was seen at 12 h, followed by necrosis that appeared around central veins at 24 h and persisted to 48 h. In D-GalN-injected mice, the first histopathological signs of liver injury appeared at 48 h. In the livers of D-GalN-treated rats, moderate pericentral inflammatory infiltration occurred after 12 h, 24 h, and 48 h, accompanied by increased proliferation and apoptosis. All histological changes were accompanied by decreasing expression of certain genes. In most experimental groups of rats and mice, both histological and molecular parameters returned to the baseline values between 48 h and 7 days after intoxication. Conclusions: In mice and rats with CCl4-induced ALF, signs of liver failure can be seen as early as 12 h and develop to 48 h. In the D-GalN-induced model, mice are more resistant to the hepatotoxic effect than rats (after 12 h), and the early hepatitis phase can be observed much later, after 48 h. These cut-off points seem to be optimal for suppressing inflammation and applying effective stem cell therapy for acute liver injury.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Assessment of animal experimental models of toxic liver injury in the context of their potential application as preclinical models for cell therapy
    Czekaj, Piotr
    Krol, Mateusz
    Limanowka, Lukasz
    Michalik, Marcin
    Lorek, Katarzyna
    Gramignoli, Roberto
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 861
  • [2] Dynamics of Chronic Liver Injury in Experimental Models of Hepatotoxicity
    Czekaj, Piotr
    Krol, Mateusz
    Kolanko, Emanuel
    Limanowka, Lukasz
    Prusek, Agnieszka
    Skubis-Sikora, Aleksandra
    Bogunia, Edyta
    Sikora, Bartosz
    Hermyt, Mateusz
    Michalik, Marcin
    Grajoszek, Aniela
    Pajak, Jacek
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (05):
  • [3] Advances in Stem Cell and Cell-Based Gene Therapy Approaches for Experimental Acute Lung Injury: A Review of Preclinical Studies
    Mei, Shirley H. J.
    dos Santos, Claudia C.
    Stewart, Duncan J.
    HUMAN GENE THERAPY, 2016, 27 (10) : 802 - 812
  • [4] Experimental models of hepatotoxicity related to acute liver failure
    Maes, Michael
    Vinken, Mathieu
    Jaeschke, Hartmut
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 290 : 86 - 97
  • [5] Adult stem cell-derived liver stem cells as models for hepatotoxicity
    Alison, Malcolm R.
    MUTAGENESIS, 2006, 21 (04) : 283 - 283
  • [6] Adult stem cell-derived liver stem cells as models for hepatotoxicity
    Alison, Malcolm R.
    TOXICOLOGY, 2006, 226 (01) : 34 - 34
  • [7] Preclinical Studies of Stem Cell Therapy for Heart Disease
    Tompkins, Bryon A.
    Balkan, Wayne
    Winkler, Johannes
    Gyongyosi, Mariann
    Goliasch, Georg
    Fernandez-Aviles, Francisco
    Hare, Joshua M.
    CIRCULATION RESEARCH, 2018, 122 (07) : 1006 - 1020
  • [8] Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic Review
    Sullivan, K. J.
    McIntyre, L. A.
    Moher, D.
    Fergusson, D.
    Mei, S. H. J.
    Lalu, M. M.
    Marshall, J. C.
    Mcleod, M.
    Griffin, G.
    Grimshaw, J.
    Turgeon, A.
    Avey, M.
    Fishman, J.
    Christou, G.
    Stewart, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [9] Mesenchymal stem cell therapy for focal epilepsy: A systematic review of preclinical models and clinical studies
    Ramos-Fresnedo, Andres
    Perez-Vega, Carlos
    Domingo, Ricardo A.
    Lee, Seung Jin
    Perkerson, Ralph B.
    Zubair, Abba C.
    Takahisa, Kanekiyo
    Tatum, William
    Quinones-Hinojosa, Alfredo
    Middlebrooks, Erik. H.
    Grewal, Sanjeet S.
    EPILEPSIA, 2022, 63 (07) : 1607 - 1618
  • [10] Regenerative Rehabilitation and Stem Cell Therapy Targeting Chronic Spinal Cord Injury: A Review of Preclinical Studies
    Tashiro, Syoichi
    Nakamura, Masaya
    Okano, Hideyuki
    CELLS, 2022, 11 (04)